Biomateriales y Nanomedicina
BioNanoMed
Instituto de Nanociencia y Materiales de Aragón
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Nanociencia y Materiales de Aragón (6)
2019
-
A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 144, pp. 165-173
-
Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 145, pp. 65-75
2017
-
Clinical advances of nanocarrier-based cancer therapy and diagnostics
Expert Opinion on Drug Delivery, Vol. 14, Núm. 1, pp. 75-92
2016
-
Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein
International Journal of Pharmaceutics, Vol. 514, Núm. 1, pp. 142-149
2015
-
Lipid nanoparticles for cyclosporine a administration: Development, characterization, and in vitro evaluation of their immunosuppression activity
International Journal of Nanomedicine, Vol. 10, pp. 6541-6553
2014
-
In vitro intestinal co-culture cell model to evaluate intestinal absorption of Edelfosine lipid nanoparticles
Current Topics in Medicinal Chemistry, Vol. 14, Núm. 9, pp. 1124-1132